Skip to main content

Currently Skimming:

Acronyms
Pages 79-82

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 79...
... Acronyms ACOSOG American College of Surgeons Oncology Group ACRIN American College of Radiology Imaging Network AE adverse event ALChEMIST Adjuvant Lung Cancer Enrichment Marker Identification in Sequencing Trial ALK anaplastic lymphoma kinase AML acute myeloid leukemia ASCO American Society of Clinical Oncology BIQSFP Biomarker, Imaging, and Quality of Life Studies Funding Program BRAF human homolog B of v-raf (Rapidly Accelerated Fibrosarcoma viral oncogene) CALGB Cancer and Leukemia Group B CCOP Community Clinical Oncology Program CDER Center for Drug Evaluation and Research CDMS Common IT Data Management System CIRB Central Institutional Review Board CLIA Clinical Laboratory Improvement Amendments CMS Centers for Medicare & Medicaid Services CRADA Cooperative Research and Development Agreement 79
From page 80...
... DNA deoxyribonucleic acid ECOG Eastern Cooperative Oncology Group EGFR epidermal growth factor receptor EMA European Medicines Agency FDA Food and Drug Administration FLT3 fms-like tyrosine kinase 3 (fms is the receptor for macrophage colony stimulating factor) GOG Gynecologic Oncology Group HER2 human epidermal growth factor receptor 2 IDE Investigational Device Exemption IND Investigational New Drug IOM Institute of Medicine IP intellectual property IRB institutional review board IRF independent radiology facility IT information technology KRAS Kirsten rat sarcoma oncogene NCCCP NCI Community Cancer Centers Program NCCTG North Central Cancer Treatment Group NCI National Cancer Institute NCORP NCI Community Oncology Research Program NCPF National Cancer Policy Forum NCRI National Cancer Research Institute (in the UK)
From page 81...
... ACRONYMS 81 NCTN National Clinical Trial Network NEWDIGS New Drug Development Paradigms NGS next-generation sequencing NHS National Health Service NIH National Institutes of Health NIHR National Institute of Health Research (in the UK) OEWG Operational Efficiency Working Group PET positron emission tomography PFS progression-free survival PTEN phosphatase and tensin homolog RATIFY Randomized AML Trial In FLT3 in <60 Year olds RFA request for application RTOG Radiation Therapy Oncology Group SEMATECH Semiconductor Manufacturing Technology SOP standard operating procedure SSC Scientific Steering Committee START Standard Terms of Agreement for Research Trials


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.